Lenalidomide overcomes the resistance to third-generation CD19-CAR-T cell therapy in preclinical models of diffuse large B-cell lymphoma
Zhen Jin, Rufang Xiang, Kai Qing, Dan Li, Zhao Liu, Xiaoyang Li, Hongming Zhu, Yunxiang Zhang, Lining Wang, Kai Xue, Han Liu, Zizhen Xu, Yingxiao Wang, Junmin Li
Topics & Concepts
LenalidomideMedicineDiffuse large B-cell lymphomaLymphomaCD19Cancer researchOncologyInternal medicineImmunologyMultiple myelomaFlow cytometryCAR-T cell therapy researchCutaneous lymphoproliferative disorders researchLymphoma Diagnosis and Treatment